Quoin Pharmaceuticals, Ltd (QNRX) insider trading
Every open-market stock purchase and sale by Quoin Pharmaceuticals, Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $188K over the last 12 months (1 buy).
- Last insider buy: Dennis Langer (Director), $188K, 12 months ago.
Last 12 months: insiders bought $188K (1 buy) and sold $0 (0 sales). Last close $4.57 on Jun 7, 2026.
Recent QNRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Feb 4, 2026 | Dennis Langer (Director) | Bought (not open market) | — |
| Feb 4, 2026 | Sally Bridget Lawlor (CFO) | Bought (not open market) | — |
| Feb 4, 2026 | Michael T Sember (Director) | Bought (not open market) | — |
| Feb 4, 2026 | Anthony James Culverwell (Director) | Bought (not open market) | — |
| Feb 4, 2026 | Natalie Ee Mun Leong (Director) | Bought (not open market) | — |
| Feb 4, 2026 | Denise P. Carter (COO) | Bought (not open market) | — |
| Feb 4, 2026 | Michael Myers (CEO) | Bought (not open market) | — |
| Feb 4, 2026 | Joseph Patrick Cooper (Director) | Bought (not open market) | — |
| Dec 1, 2025 | Sally Bridget Lawlor (CFO) | Bought (not open market) | — |
| Oct 14, 2025 | Dennis Langer (Director) | Bought | $188K |
Who's trading QNRX
- Michael T Sember, Director: other filings, last Feb 4, 2026
- Joseph Patrick Cooper, Director: other filings, last Feb 4, 2026
- Anthony James Culverwell, Director: other filings, last Feb 4, 2026
- Denise P. Carter, COO: other filings, last Feb 4, 2026
- Dennis Langer, Director: bought $188K (1 buy), last Feb 4, 2026
- Sally Bridget Lawlor, CFO: other filings, last Feb 4, 2026
- Natalie Ee Mun Leong, Director: other filings, last Feb 4, 2026
- Michael Myers, CEO: other filings, last Feb 4, 2026
Get free alerts when an insider at Quoin Pharmaceuticals, Ltd files a new trade →